FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2789991075> ?p ?o ?g. }

• W2789991075 endingPage "9" @default.
• W2789991075 startingPage "1" @default.
• W2789991075 abstract "Human adenoviruses (AdV) cause generally mild infections of the respiratory and GI tracts as well as some other tissues. However, AdV can cause serious infection in severely immunosuppressed individuals, especially pediatric patients undergoing allogeneic hematopoietic stem cell transplantation, where mortality rates are up to 80% with disseminated disease. Despite the seriousness of AdV disease, there are no drugs approved specifically to treat AdV infections. We report here that USC-087, an N-alkyl tyrosinamide phosphonate ester prodrug of HPMPA, the adenine analog of cidofovir, is highly effective against multiple AdV types in cell culture. USC-087 is also effective against AdV-C6 in our immunosuppressed permissive Syrian hamster model. In this model, hamsters are immunosuppressed by treatment with high dose cyclophosphamide. Injection of AdV-C6 (or AdV-C5) intravenously leads to a disseminated infection that resembles the disease seen in humans, including death. We have tested the efficacy of orally-administered USC-087 against the median lethal dose of intravenously administered AdV-C6. USC-087 completely prevented or significantly decreased mortality when administered up to 4 days post challenge. USC-087 also prevented or significantly decreased liver damage caused by AdV-C6 infection, and suppressed virus replication even when administered 4 days post challenge. These results imply that USC-087 is a promising candidate for drug development against HAdV infections." @default.
• W2789991075 created "2018-03-29" @default.
• W2789991075 creator A5004508225 @default.
• W2789991075 creator A5008195724 @default.
• W2789991075 creator A5011933351 @default.
• W2789991075 creator A5019604750 @default.
• W2789991075 creator A5030143515 @default.
• W2789991075 creator A5032387026 @default.
• W2789991075 creator A5036455936 @default.
• W2789991075 creator A5041489306 @default.
• W2789991075 creator A5063877596 @default.
• W2789991075 creator A5068224830 @default.
• W2789991075 creator A5069979824 @default.
• W2789991075 creator A5077656155 @default.
• W2789991075 creator A5081236075 @default.
• W2789991075 creator A5082814141 @default.
• W2789991075 creator A5089341848 @default.
• W2789991075 date "2018-05-01" @default.
• W2789991075 modified "2023-10-04" @default.
• W2789991075 title "USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses" @default.
• W2789991075 cites W1131682946 @default.
• W2789991075 cites W1251295525 @default.
• W2789991075 cites W1558640687 @default.
• W2789991075 cites W17101588 @default.
• W2789991075 cites W1817983227 @default.
• W2789991075 cites W1968596822 @default.
• W2789991075 cites W1970250038 @default.
• W2789991075 cites W1976868395 @default.
• W2789991075 cites W1979888508 @default.
• W2789991075 cites W1982015427 @default.
• W2789991075 cites W1982693802 @default.
• W2789991075 cites W2001843565 @default.
• W2789991075 cites W2004785370 @default.
• W2789991075 cites W2021485239 @default.
• W2789991075 cites W2025561765 @default.
• W2789991075 cites W2037183326 @default.
• W2789991075 cites W2041854719 @default.
• W2789991075 cites W2046223578 @default.
• W2789991075 cites W2046950930 @default.
• W2789991075 cites W2047654743 @default.
• W2789991075 cites W2055363307 @default.
• W2789991075 cites W2062597360 @default.
• W2789991075 cites W2062932127 @default.
• W2789991075 cites W2064057886 @default.
• W2789991075 cites W2065054334 @default.
• W2789991075 cites W2077987590 @default.
• W2789991075 cites W2078390252 @default.
• W2789991075 cites W2092976200 @default.
• W2789991075 cites W2093204006 @default.
• W2789991075 cites W2118279792 @default.
• W2789991075 cites W2121053847 @default.
• W2789991075 cites W2122522262 @default.
• W2789991075 cites W2124494865 @default.
• W2789991075 cites W2132651963 @default.
• W2789991075 cites W2141520899 @default.
• W2789991075 cites W2150887034 @default.
• W2789991075 cites W2159604048 @default.
• W2789991075 cites W2159819482 @default.
• W2789991075 cites W2186475822 @default.
• W2789991075 cites W2330021725 @default.
• W2789991075 cites W2340809593 @default.
• W2789991075 cites W2418777691 @default.
• W2789991075 cites W2420941478 @default.
• W2789991075 cites W2493441801 @default.
• W2789991075 cites W2509764326 @default.
• W2789991075 cites W2511995092 @default.
• W2789991075 cites W2524966893 @default.
• W2789991075 cites W2552740654 @default.
• W2789991075 cites W2559041011 @default.
• W2789991075 cites W2570671915 @default.
• W2789991075 cites W2581794847 @default.
• W2789991075 cites W2593260449 @default.
• W2789991075 cites W2767264783 @default.
• W2789991075 cites W410031583 @default.
• W2789991075 cites W4211223184 @default.
• W2789991075 cites W90840010 @default.
• W2789991075 cites W996792636 @default.
• W2789991075 doi "https://doi.org/10.1016/j.antiviral.2018.03.001" @default.
• W2789991075 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5891362" @default.
• W2789991075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29510156" @default.
• W2789991075 hasPublicationYear "2018" @default.
• W2789991075 type Work @default.
• W2789991075 sameAs 2789991075 @default.
• W2789991075 citedByCount "15" @default.
• W2789991075 countsByYear W27899910752018 @default.
• W2789991075 countsByYear W27899910752019 @default.
• W2789991075 countsByYear W27899910752020 @default.
• W2789991075 countsByYear W27899910752021 @default.
• W2789991075 countsByYear W27899910752022 @default.
• W2789991075 countsByYear W27899910752023 @default.
• W2789991075 crossrefType "journal-article" @default.
• W2789991075 hasAuthorship W2789991075A5004508225 @default.
• W2789991075 hasAuthorship W2789991075A5008195724 @default.
• W2789991075 hasAuthorship W2789991075A5011933351 @default.
• W2789991075 hasAuthorship W2789991075A5019604750 @default.
• W2789991075 hasAuthorship W2789991075A5030143515 @default.
• W2789991075 hasAuthorship W2789991075A5032387026 @default.
• W2789991075 hasAuthorship W2789991075A5036455936 @default.

• next